News
A multinational clinical project (OligoG-pivotal-CF) to test the orphan drug OligoG CF-5/20 (OligoG) in a pivotal phase IIb clinical trial for the treatment of cystic fibrosis (CF).
A multinational clinical project (OligoG-pivotal-CF) to test the orphan drug OligoG CF-5/20 (OligoG) in a pivotal phase IIb clinical trial for the treatment of cystic fibrosis (CF).
AlgiPharma’s Cystic Fibrosis drug candidate OligoG awarded pivotal trial grant of €6 million from EU’s Horizon 2020 programme
/in News /by rogerhenriksenAn EU Horizon 2020 proposal (OligoGpivotalCF) submitted by a consortium assembled by AlgiPharma, has been successful in winning a grant of EUR 6 million to support AlgiPharma’s cystic fibrosis drug candidate OligoG through a pivotal clinical trial program.